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Purpose
Kawasaki Disease is the most common vasculitis of
childhood, and carries considerable morbidity with risk
of development of coronary artery aneurysms. Serologi-
cal predictors of the development of coronary artery
aneurysms have not yet been found. FSTL-1 is a pro-
inflammatory protein which is produced by mesenchy-
mal tissue, including cardiac myocytes, and has been
found to be elevated in inflammatory disorders such as
Juvenile Idiopathic Arthritis. The current study was
designed to determine if plasma levels of FSTL-1 corre-
late with the development of Kawasaki Disease and
development of coronary artery aneurysms.
Methods
FSTL-1 plasma levels were measured by ELISA in 48
patients with Kawasaki Disease at time of diagnosis
(acute) and, 2 weeks, 6 weeks and 6 months following
onset of disease. These were compared with plasma
from 23 age-matched controls. In addition, FSTL-1
plasma levels were measured in 6 patients who devel-
oped coronary artery aneurysms. Data was analyzed
using student’s t-test to evaluate for differences between
FSTL-1 levels at different time points, and between
patients who did or did not develop aneurysms.
Results
FSTL-1 levels were significantly elevated in patients with
acute Kawasaki Disease as compared to age-matched
controls (mean 161.7 ng/ml vs. 121.3 ng/ml, p<0.001).
The highest levels of FSTL-1 were observed in patients
who developed coronary aneurysms (mean 225.5 ng/ml,
p=0.005 compared to the acute time point ). FSTL-1
levels diminished during the subacute and convalescent
phases of disease but still remained significantly elevated
at 2 weeks and 6 weeks after disease onset. FSTL-1
levels returned to normal by 6 months.
Conclusion
Plasma levels of FSTL-1 are elevated in acute Kawasaki
Disease. Furthermore, FSTL-1 might be a valuable bio-
marker for predicting cardiac morbidity in this disease.
Additionally, since FSTL-1 is produced by cardiac myo-
cytes, these results suggest a possible role for FSTL-1 in
the formation of coronary artery aneurysms.
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